323 related articles for article (PubMed ID: 36443703)
1. Epidemiological study of HPV infection in 40,693 women in Putian: a population study based on screening for high-risk HPV infection.
Chen Z; Lin H; Zheng J; Cai L; Chen Z; Li J; Yu L
BMC Infect Dis; 2022 Nov; 22(1):893. PubMed ID: 36443703
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and genotypes analysis of human papillomavirus infection in Beijing, China.
Wang J; Li H; Zhang J; Wang H; Li Y; Liu Z; Liu H
Virol J; 2024 Jan; 21(1):19. PubMed ID: 38229145
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
[No Abstract] [Full Text] [Related]
4. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
Rosário A; Sousa A; Marinho-Dias J; Medeiros R; Lobo C; Leça L; Coimbra N; Tavares F; Baldaque I; Martins G; Monteiro P; Henrique R; Sousa H
J Med Virol; 2023 Jan; 95(1):e28414. PubMed ID: 36541747
[TBL] [Abstract][Full Text] [Related]
5. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of human papillomavirus infection among women with cervical cytological abnormalities in the Zhoupu District, Shanghai City, China, 2014-2019.
Li P; Liu Q; Li W; Liu Z; Xing B; Wu S; Zhou Z; Sun L; Ren H; Li H; Li H
Virol J; 2021 Mar; 18(1):51. PubMed ID: 33685499
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and genotype distribution of high-risk human papillomavirus infection among women with cervical cytological abnormalities in Chongqing, China, 2014-2020.
Luo Q; Lang L; Han N; Liang L; Shen L; Zhang H
Diagn Cytopathol; 2021 Dec; 49(12):1237-1243. PubMed ID: 34708933
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of women infected with human papillomavirus in a tertiary hospital in Beijing China, 2014-2018.
Ma L; Lei J; Ma L; Cong X; Wang N; Yang H; Liu Q; Yu Y; Cao Y
BMC Infect Dis; 2019 Jul; 19(1):670. PubMed ID: 31357941
[TBL] [Abstract][Full Text] [Related]
9. High-risk Human Papillomavirus Infection in Putian, China: A Cross-sectional Analysis of 98085 Women.
Zhang R; Hong G; Liao C; Chen Z; Lin H; Yu L
J Coll Physicians Surg Pak; 2023 Jun; 33(6):642-646. PubMed ID: 37300259
[TBL] [Abstract][Full Text] [Related]
10. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of prophylactic HPV vaccines against cervical abnormalities and HPV infection in Japan: The J-HERS 2021 multicenter study.
Saeki Y; Saito M; Irie T; Itoh F; Enatsu A; Komura H; Fujii M; Fujii R; Hidaka N; Maehama T; Shirasu N; Waseda T; Shibata T; Takada E; Mibe K; Sakamoto J; Yamada S; Takakura M; Sasagawa T
J Med Virol; 2024 Feb; 96(2):e29413. PubMed ID: 38314927
[TBL] [Abstract][Full Text] [Related]
12. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.
Tao X; Zhang H; Zhang H; Xiao Y; Zhong F; Zhou X; Cong Q; Sui L; Zhao C
Cancer Cytopathol; 2022 Jul; 130(7):542-550. PubMed ID: 35312217
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of human papillomavirus infection in women from Xiamen, China, 2013 to 2023.
Yao X; Li Q; Chen Y; Du Z; Huang Y; Zhou Y; Zhang J; Wang W; Zhang L; Xie J; Xu C; Ge Y; Zhou Y
Front Public Health; 2024; 12():1332696. PubMed ID: 38590815
[TBL] [Abstract][Full Text] [Related]
14. National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study.
Smith MA; Sherrah M; Sultana F; Castle PE; Arbyn M; Gertig D; Caruana M; Wrede CD; Saville M; Canfell K
BMJ; 2022 Mar; 376():e068582. PubMed ID: 35354610
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
[TBL] [Abstract][Full Text] [Related]
16. Distribution of cervical lesions in high-risk HPV (hr-HPV) positive women with ASC-US: a retrospective single-center study in China.
Wang Z; Gu Y; Wang H; Chen J; Zheng Y; Cui B; Yang X
Virol J; 2020 Nov; 17(1):185. PubMed ID: 33228715
[TBL] [Abstract][Full Text] [Related]
17. Clinical and epidemiological features of high-risk human papillomavirus infection in patients with cervical intraepithelial lesions.
Ding YQ; Yu J; Wang RQ; Sang L
BMC Womens Health; 2023 Sep; 23(1):468. PubMed ID: 37658312
[TBL] [Abstract][Full Text] [Related]
18. The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.
Beyazit F; Sılan F; Gencer M; Aydin B; Paksoy B; Unsal MA; Ozdemir O
Ginekol Pol; 2018; 89(2):62-67. PubMed ID: 29512809
[TBL] [Abstract][Full Text] [Related]
19. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of high-risk human papillomavirus and cervical lesion risk factors: A population-based study in Zhejiang, China 2010-2019.
Lu W; Chen T; Yao Y; Chen P
J Med Virol; 2021 Aug; 93(8):5118-5125. PubMed ID: 33913528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
